Skip to nav Skip to content

Global Health

Facebook Twitter LinkedIn Email

IDSA prioritizes promoting sufficient US investment in global infectious diseases responses and research, and in using the voices of physician scientists to inform multilateral and national global health policies. IDSA is a trusted leader in shaping and advancing international and national policies and investments in global HIV, TB, health security and antimicrobial resistance.


Congress Recognizes Value of PEPFAR with Reauthorization; Funding Increases will be Critical
The Senate's approval reauthorizing PEPFAR acknowledges the program's role in reversing the trajectory of the AIDS pandemic and boosting responses against ID worldwide.
Click here to read more.

IDSA Urges Strengthened U.S. Leadership of Global Health Security Agenda 11/6/2018
As Global Health Security Agenda partners meet in Indonesia this week to commit to their next steps in improving epidemic readiness worldwide, the Infectious Diseases Society of America is asking the U.S. Department of Health and Human Services to strengthen its leadership of efforts through the partnership.
Click here to read more.

World Bank, IMF must Focus on Global Health Funding and Capacity 4/20/2018
The Infectious Diseases Society of America appreciates the attention that the World Bank and International Monetary Fund will give to critical global health issues during their spring meetings and civil society forum.
Click here to read more. 

House Testimony on Global Health Programs 4/20/2018
IDSA urges for increased funding for State Department and USAID global health programs in this testimony submitted to the House Appropriations Committee. 
Click here to read more. 

Hank Tomlinson, Ph.D. to Lead CDC’s Global HIV and TB Efforts at Critical Time 4/18/2018
The U.S. government response to the global impacts of HIV and tuberculosis is poised at a pivotal moment, in which we can seize the opportunity to end these devastating pandemics, or watch progress erode, infections increase, and our effective treatments compromised by growing drug resistance. 
Click here to read more. 

PEPFAR report serves as a beacon and a warning 4/12/2018
The 2018 Annual Report to Congress released by the United States President’s
Emergency Plan for AIDS Relief (PEPFAR) tells a story of remarkable progress and opportunity. Click here to read more. 

Statement on World Health Day 04/20/2018
On World Health Day, the Infectious Diseases Society of America and the
HIV Medicine Association appreciate the global leadership of the United States
in responding to infectious disease threats that know no boundaries.
Click here to
Click here for IDSA/HIVMA Global Impact: 2018 and Beyond.

Statement on World TB Day 03/23/2018
Commemoration of World TB Day finds us at a promising but pivotal moment. Advances in diagnostic tools, medications, and treatment regimens are offering significant improvements to detect, treat and control tuberculosis. Click here to read more. 

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.